Young Cancer Survivors Face Double Risk
Analysis based on 6 articles · First reported Apr 13, 2026 · Last updated Apr 15, 2026
The research findings could lead to increased demand for cancer screening technologies and treatments, potentially benefiting pharmaceutical and healthcare companies. It also highlights a growing population of cancer survivors who may require long-term medical care, impacting healthcare resource allocation.
Research from Canada — Alberta, led by Miranda Fidler-Benaoudia and published in the Canadian Medical Association, indicates that survivors of cancer in their teen and young adult years face double the risk of developing subsequent cancers. The Canada — Alberta Adolescent and Young Adult Cancer Survivor Study, which included 24,459 people diagnosed between 1983 and 2017, found that 1 in 6 survivors will experience a new cancer within 30 years of their initial diagnosis. This increased risk is attributed to late effects of treatments like radiotherapy, chemotherapy, and hormone therapy, with genetic factors also playing a role. The study suggests the need for earlier cancer surveillance and innovative solutions for prevention, detection, and treatment of subsequent primary neoplasms among this growing population of survivors in Canada.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard